Vaxart Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Vaxart Inc
VXRT Stock  USD 0.57  0.01  1.72%   
Vaxart financial statements provide useful quarterly and yearly information to potential Vaxart Inc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Vaxart financial statements helps investors assess Vaxart's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Vaxart's valuation are summarized below:
Gross Profit
-49.5 M
Market Capitalization
130.9 M
Enterprise Value Revenue
4.0777
Revenue
16.8 M
Earnings Share
(0.40)
There are currently one hundred twenty fundamental trend indicators for Vaxart Inc that can be evaluated and compared over time across competition. All traders should double-check Vaxart's current fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 139.5 M in 2025. Enterprise Value is likely to gain to about 127.8 M in 2025

Vaxart Total Revenue

6.31 Million

Check Vaxart financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxart's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.1 M, Interest Expense of 1.4 M or Total Revenue of 6.3 M, as well as many indicators such as Price To Sales Ratio of 9.61, Dividend Yield of 0.0 or PTB Ratio of 2.34. Vaxart financial statements analysis is a perfect complement when working with Vaxart Valuation or Volatility modules.
  
Check out the analysis of Vaxart Correlation against competitors.

Vaxart Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets150.6 M105.6 M95.8 M
Slightly volatile
Short and Long Term Debt Total29.3 M23.9 M11 M
Slightly volatile
Other Current Liabilities9.8 M5.1 M7 M
Very volatile
Total Current Liabilities17.6 M12.4 M12.3 M
Pretty Stable
Total Stockholder Equity89.3 M66.5 M67.4 M
Slightly volatile
Property Plant And Equipment Net27.5 M32.9 M11.4 M
Slightly volatile
Cash52.2 M40 M55.6 M
Very volatile
Non Current Assets Total40.4 M41.7 M20.9 M
Slightly volatile
Cash And Short Term Investments61.2 M45.7 M64.8 M
Pretty Stable
Net Receivables2.6 M2.7 M4.5 M
Slightly volatile
Common Stock Shares Outstanding174.9 M166.5 M54.4 M
Slightly volatile
Liabilities And Stockholders Equity150.6 M105.6 M95.8 M
Slightly volatile
Non Current Liabilities Total27.5 M18.3 M14.5 M
Slightly volatile
Other Current Assets4.7 M2.5 M2.1 M
Slightly volatile
Other Stockholder Equity564.3 M537.5 M248.6 M
Slightly volatile
Total Liabilities44.6 M30.6 M26.8 M
Slightly volatile
Property Plant And Equipment Gross24.7 M39.1 M10.4 M
Slightly volatile
Total Current Assets95 M52.4 M73.2 M
Pretty Stable
Short Term Debt6.1 M5.9 M1.9 M
Slightly volatile
Accounts Payable1.4 M1.4 M3.2 M
Slightly volatile
Common Stock Total Equity11.1 K11.7 K2.3 M
Slightly volatile
Common Stock12.8 K13.5 K2 M
Slightly volatile
Capital Surpluse528.9 M503.7 M271.7 M
Slightly volatile
Property Plant Equipment18.8 M17.9 M5.3 M
Slightly volatile
Non Current Liabilities Other3.2 M3.4 M6.4 M
Pretty Stable
Deferred Long Term Asset Charges560 K450 K600.6 K
Slightly volatile
Long Term Debt Total2.1 M2.2 M3.5 M
Very volatile
Net Invested Capital82.7 M66.5 M50.3 M
Slightly volatile
Net Working Capital68.8 M36.6 M47.2 M
Slightly volatile
Capital Stock12.8 K13.5 K708.1 K
Pretty Stable
Capital Lease Obligations14.2 M23.1 M7.6 M
Slightly volatile

Vaxart Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization8.1 M7.8 M3.1 M
Slightly volatile
Total Revenue6.3 M6.6 M16.7 M
Slightly volatile
Other Operating Expenses75.8 M81.7 M53.4 M
Slightly volatile
Cost Of Revenue53.4 M61.3 M29.3 M
Slightly volatile
Total Operating Expenses109.6 M104.3 M49.1 M
Slightly volatile
Selling General Administrative21.2 M20.3 M13.3 M
Slightly volatile
Research Development82.3 M78.4 M35.4 M
Slightly volatile
Interest Income3.2 M3 M729.9 K
Slightly volatile
Reconciled Depreciation10.4 M9.9 M3.3 M
Slightly volatile
Preferred Stock And Other Adjustments271.2 K305.1 K332.6 K
Slightly volatile
Selling And Marketing Expenses3.6 M4 M4.4 M
Slightly volatile

Vaxart Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation8.1 M7.8 M3.4 M
Slightly volatile
End Period Cash Flow53.6 M40 M55.8 M
Very volatile
Begin Period Cash Flow52.3 M52.9 M53.3 M
Pretty Stable
Stock Based Compensation17.1 M16.3 M5.7 M
Slightly volatile
Issuance Of Capital Stock12.9 M13.5 M29.7 M
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio9.6110.12137
Slightly volatile
Days Sales Outstanding14113490.4501
Pretty Stable
Stock Based Compensation To Revenue1.641.729.0264
Slightly volatile
Capex To Depreciation0.240.251.0699
Pretty Stable
Inventory Turnover1.781.881.8288
Slightly volatile
Days Of Inventory On Hand21120158.9242
Slightly volatile
Payables Turnover51.9549.4716.6159
Slightly volatile
Sales General And Administrative To Revenue2.622.7519.8043
Slightly volatile
Average Inventory945 K900 K240.3 K
Slightly volatile
Research And Ddevelopement To Revenue7.98.3153.713
Slightly volatile
Capex To Revenue0.220.236.0668
Pretty Stable
Cash Per Share0.230.2523.5747
Slightly volatile
Days Payables Outstanding7.257.6487.8407
Very volatile
Intangibles To Total Assets0.140.110.1162
Pretty Stable
Current Ratio3.712.995.992
Pretty Stable
Receivables Turnover2.682.826.7743
Pretty Stable
Capex Per Share0.01410.01491.6572
Slightly volatile
Revenue Per Share0.05570.058614.7628
Slightly volatile
Interest Debt Per Share0.210.222.7711
Slightly volatile
Debt To Assets0.40.260.6495
Very volatile
Graham Number169112122
Slightly volatile
Operating Cycle89.39134106
Pretty Stable
Days Of Payables Outstanding7.257.6487.8407
Very volatile
Ebt Per Ebit1.361.130.9912
Slightly volatile
Long Term Debt To Capitalization0.04740.04990.0445
Pretty Stable
Total Debt To Capitalization0.270.281.7531
Very volatile
Quick Ratio3.372.995.9442
Pretty Stable
Net Income Per E B T0.620.90.9579
Very volatile
Cash Ratio2.292.284.4459
Pretty Stable
Days Of Inventory Outstanding21120158.9242
Slightly volatile
Days Of Sales Outstanding14113490.4501
Pretty Stable
Fixed Asset Turnover0.170.1823.188
Slightly volatile
Debt Ratio0.40.260.6495
Very volatile
Price Sales Ratio9.6110.12137
Slightly volatile
Asset Turnover0.08780.09240.2599
Slightly volatile

Vaxart Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap139.5 M74.7 M187.4 M
Very volatile

Vaxart Fundamental Market Drivers

Forward Price Earnings42.735
Cash And Short Term Investments39.7 M

Vaxart Upcoming Events

20th of March 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Vaxart Financial Statements

Vaxart shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Vaxart investors may analyze each financial statement separately, they are all interrelated. The changes in Vaxart's assets and liabilities, for example, are also reflected in the revenues and expenses on on Vaxart's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-952.2 K-904.6 K
Total Revenue6.6 M6.3 M
Cost Of Revenue61.3 M53.4 M
Stock Based Compensation To Revenue 1.72  1.64 
Sales General And Administrative To Revenue 2.75  2.62 
Research And Ddevelopement To Revenue 8.31  7.90 
Capex To Revenue 0.23  0.22 
Revenue Per Share 0.06  0.06 
Ebit Per Revenue(12.99)(13.64)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vaxart Stock Analysis

When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY